Clinical Trials
15 trialsNCT07574684 2026-05-08
ALA /NSCLC
Ain Shams University
Phase 2 Not yet recruiting
NCT05297734 2026-04-30
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Phase NA Recruiting
NCT04678648 2026-03-18
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
Phase 1 Recruiting
NCT07274384 2025-12-10
HYPERBOLIC
Università Vita-Salute San Raffaele
Phase 2 Not yet recruiting
NCT04300062 2025-09-03
REBIMMUNE
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT03154190 2025-01-24
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
Phase NA Completed
NCT04436120 2024-12-03
TRANSLATE
Pfizer
Phase NA Terminated
NCT06622174 2024-10-02
PROMISE
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 1 Not yet recruiting
NCT03546426 2024-10-01
MESOVAX
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 1 Active not recruiting
NCT05663242 2023-05-30
The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase 4 Recruiting
NCT04005144 2022-10-17
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer
University of California, San Francisco
Phase 1 Terminated
NCT02586987 2019-11-18
A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Completed
NCT02538432 2019-11-04
Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors
University of Maryland, Baltimore
Phase 2 Withdrawn
NCT01355965 2017-09-19
Autologous Redirected RNA Meso-CIR T Cells
University of Pennsylvania
Phase 1 Completed
NCT01210131 2013-08-27
HX4 in SCLC
Maastricht Radiation Oncology
Phase NA Withdrawn